Poster Session II - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.01 - REHABILITATION P832 - ESOC25-1295 POST-STROKE FACIAL PALSY: PREVALENCE ON ADMISSION, RISK FACTORS, AND RECOVERY WITH HYPER-ACUTE TREATMENTS Zewen Lu 1 , Havva Eroglu 2 , Halvor Nss 3 , Matthew Gittins 1 , Amit Kishore 4 , Craig Smith 5 , Andy Vail 1 , Claire Mitchell 2 1 Centre for Biostatistics, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, 2 Division of Psychology, Communication & Human Neuroscience, Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester, United Kingdom, 3 Department of Neurology, University of Bergen, Haukeland University Hospital, Bergen, Norway, 4 Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, 5 Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, Manchester, United Kingdom Background and Aims: Facial palsy affects 40 - 50% of stroke survivors, impacting quality of life, communication, and emotional expression
These findings highlight Ses dual role as both an antioxidant and a pro-oxidant at elevated concentrations
FDA routinely conducts similar, web-based inspections, which are well suited to reveal a products intended use often the determining factor in whether a product is a drug. See 21 CFR 201.128 (intended use can be derived from a broad array of objective factors, including labeling claims, advertising matter, or oral or written statements.) See also 21 USC 321(g) (defining drug based on, inter alia, its intended use)
(This process involves the breakdown of pyruvate into carbon dioxide and water
Fecal microbiota transplantation in Parkinsons diseaseA randomized repeat-dose, placebo-controlled clinical pilot study
